THE PATHOLOGY OF MELANOMA:

AN INTERNATIONAL COURSE

APRIL 11 & 12, 2024

// OBJECTIVE

Following the success of our Courses in 2017, 2018, 2020, and 2022 the objective of the Fifth International Melanoma Course in 2024 will continue to stress due diligence and practical diagnosis of melanocytic lesions. We will emphasize the theme of “Acknowledging uncertainty and avoiding over diagnosis of melanoma”, as well as updates of all cutting-edge knowledge on difficult melanocytes lesions relevant to practicing pathologists and clinicians.

This 2024 venue will again include expertise from the SIRIC (Integrated Cancer Research Site at Institut Curie), the WHO 5th Edition Classification of Melanocytic Tumours, the revised MPATH-Dx Classification schema (2023), the MPATH Group, and the International Melanoma Pathology Study Group.

// THE REVISED MPATH-Dx CLASSIFICATION

  • The revised MPATH (Version 2.0) schema provides a simplified two category system for benign melanocytic lesions: Class I. Low-grade and Class II. High-grade lesions. Practical criteria allow for the mapping of all benign melanocytic lesions with diverse terminologies into these categories.
  • The classification of melanoma is refined by the recognition of a low-risk category of T1a melanoma in the new Class III.
  • The schema provides estimates of risk for disease progression and guidelines for practical management.

// THE COURSE PROGRAMME AND CONTENT

  • The Course will consist of didactic lectures and interactive sessions during the two-day program.
  • An approach of practical diagnosis is based on the extensive experience of the international faculty in the Course.
  • The latest advances in ancillary diagnostic techniques including immunohistochemistry and molecular genetics will be emphasized.
  • Particular attention will be given to predictive biomarkers for targeted, immune and checkpoint inhibitors therapies.

Faculty

Directors

Director of the course

List of speakers

NON EXHAUSTIVE LIST OF TOPICS